New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 4, 2014
08:20 EDTROSGRosetta Genomics to receive U.S. patent for cancer origin assay
Rosetta Genomics announced that the company received a Notice of Allowance from the United States Patent and Trademark Office for a patent covering the method of use of a core element of Rosetta Genomics' microRNA technology in the identification of the tumor of origin in cancer of unknown or uncertain primary and metastatic cancer. The issued claims for U.S. Patent Application No. 13/167,489 is entitled "Gene Expression Signature for Classification of Tissue of Origin of Tumor Samples."
News For ROSG From The Last 14 Days
Check below for free stories on ROSG the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 2, 2014
08:21 EDTROSGRosetta Genomics, Moffitt Cancer enter cancer diagnostics alliance
Rosetta Genomics announces that the company has entered into a strategic alliance with Moffitt Cancer Center, a National Cancer Institute-designated Comprehensive Cancer Center, to discover, develop and commercialize a variety of microRNA-based cancer diagnostics. Under the three-year alliance Rosetta will provide funding for Moffitt investigator-initiated projects that align with Rosetta's strategic priorities.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use